(19)
(11) EP 1 104 293 A1

(12)

(43) Date of publication:
06.06.2001 Bulletin 2001/23

(21) Application number: 99941081.4

(22) Date of filing: 13.08.1999
(51) International Patent Classification (IPC)7A61K 31/00, A61K 31/69, A61K 38/55, A61P 37/00, A61P 37/08, A61P 29/00, A61P 35/00, A61P 1/00, A61P 9/10, A61P 31/00, A61P 31/12, A61P 43/00
(86) International application number:
PCT/US9918/315
(87) International publication number:
WO 0010/549 (02.03.2000 Gazette 2000/09)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.08.1998 US 97376 P

(71) Applicant: Point Therapeutics, Inc.
Boston, MA 02111 (US)

(72) Inventor:
  • WALLNER, Barbara
    Weston, MA 02193 (US)

(74) Representative: Jump, Timothy John Simon et al
Venner Shipley & Co.20 Little Britain
London EC1A 7DH
London EC1A 7DH (GB)

   


(54) REGULATION OF SUBSTRATE ACTIVITY